Ion beam therapy with concurrent chemotherapy using Gemcitabine for unresectable pancreatic cancer, Phase I/II study
Not Applicable
- Conditions
- pancreatic cancer
- Registration Number
- JPRN-UMIN000002173
- Lead Sponsor
- Department of Radiology, Hyogo Ion Beam Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
distal metastases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method QOL survival time
- Secondary Outcome Measures
Name Time Method